Resultados de la búsqueda 61-70 of 3421 for Amphotericin B
... B (Vendor:product name). If product name has spaces in it, utilize an underscore (_) instead of spacing (i.e. microsoft:security_essentials). 4. 5. Vendor sBOM ...
The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic ...
During Part B, patients will be enrolled regardless of MYD88 mutation status. Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus ...
Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able ...
... B) of CA-4948 in patients with RR NHL with and without myeloid ... The purpose of this study is to evaluate the immune and hematopoietic compartments in patients ...
... B) of CA-4948 in patients with RR NHL with and without myeloid differentiation primary response 88 (MYD88) mutations. During Part B, patients will be ...
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies. Rochester, Minn. The purpose of this study is to find out ...
... B]. This Phase 3 study is designed to evaluate the specificity and sensitivity of 99mTc-MIP-1404 SPECT/CT imaging to correctly identify subjects with ...
Also, we will evaluate whether the peripheral blood immune cell function is different in B/AA prostate cancer patients with metastatic disease as compared with ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?